Comparison of the Efficacy of the Various Treatment Modalities in the Management of Perianal Crohn’s Fistula: A Review

Abstract

Crohn's disease (CD) is a transmural inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract. With the disease's progression, adhesions and transmural fissuring, intraabdominal abscesses, and fistula tracts may develop. An anal fistula (or fistula-in-ano) is a chronic abnormal epithelial lined tract communicating the anorectal lumen (internal opening) to the perineal or buttock skin (external opening). The risk of fistula development varies from 14%-38%. It can cause significant morbidity, which adversely impacts the quality of life. It is mostly believed that an anal crypt gland infection causes anal abscesses, leading to fistula development. Crohn's disease's pathogenesis involves Th1 and Th17 hypersensitivity due to an unknown antigen within the intestinal mucosa. Evidence to support this review was gathered via the Pubmed database. Search terms used were combinations of "Perianal fistula," "seton," "immunotherapy." Studies were reviewed and cross-referenced for additional reports. Setons are surgical thread loops passed from the external to the internal opening of the fistula tract and exteriorized through the anorectal canal, facilitating abscess drainage and inciting a local inflammatory reaction, thus promoting the resolution of the fistula. Biologicals such as anti-tumor necrosis factor (TNF) antibody (infliximab, adalimumab, certolizumab), anti-IL-12/23 (ustekinumab), and anti-α₄β₇ integrin antibody (vedolizumab) have been approved for Crohn's disease targeting the Th1/Th17-mediated inflammation. Other therapeutic modalities are fistulotomy, cyanoacrylate glue, bioprosthetic plugs, mucosal advancement flap, ligation of inter-sphincteric fistula tract (LIFT), diverting stoma, proctectomy, video-assisted anal fistula treatment (VAAFT), and fistula laser closure (FiLaC). Our review found that chronic seton therapy should be the primary approach, especially if the patient has a perianal abscess. It has a low incidence of re-intervention, recurrent abscess formation, and side-branching of the fistulous tract, with preservation of the fistulous tract's patency and cost-effectiveness. The major disadvantage of seton therapy is the discomfort and time to achieve stability. Among the biologicals, infliximab is the only therapy which has a statistically significant effect on the healing rate of perianal Crohn's fistula compared to placebo, but the major disadvantage associated with anti-TNF as sole therapy is high re-intervention rate, prolong maintenance therapy, high recurrence rate, and severe side effects. We hypothesize that the two aspects should be addressed concurrently to increase the fistula healing or closure rate. First, the seton should be used as initial therapy to maintain tract patency to allow abscess drainage and minimize the intestinal flora colonization within the tract mucosa, thereby leukocytic infiltration and propagation of inflammation within the tract. The second aspect that has to be considered is that we should target the initial stimulation of the T...

Research on high anal fistula: a bibliometric analysis

“…Traditional surgery has a high cure rate, but it has the disadvantage of damaging the anal sphincter. The sphincter-sparing surgery that has emerged over the decades has protected postoperative anal function, but the recurrence rate is significantly higher than that of traditional surgery, which has become a major obstacle to the promotion of sphincter-sparing surgery (17). Thus, looking for a new technology that can effectively retain the function of the sphincter and anus, but can also effectively reduce the recurrence rate has become a popular area of research in the treatment of anal fistula.…”

Three-dimensional pelvic ultrasound is a practical tool for the assessment of anal fistula

“…Park’s classification is an anatomically precise classification developed for surgical use based on the relationship between the fistula and the external sphincter [ 8 ]. This classification divides anal fistulas into four types: inter-sphincteric (type I), trans-sphincteric (type II), supra-sphincteric (type III), and extra-sphincteric (type IV).…”

Management of Perianal Crohn's Disease

“…Because approximately 80% of fistulas are associated with a perianal abscesses, incision and drainage (I&D) is the most common initial operative intervention (69). In addition to drainage, noncutting setons are typically used to decrease the incidence of recurrent abscess formation and the development of new fistulous tracts (70). Setons are both easy on the patient and simple to insert.…”